I bought as part of the IPO and was sold at "Hello" once I read...

  1. 8,043 Posts.
    lightbulb Created with Sketch. 483
    I bought as part of the IPO and was sold at "Hello" once I read the prospectus. Realistically what woman who could afford to do it wouldn't? Then, I thought the worst when my entire applicationwas given to me (as that usually means there is not enough demand). Yet I knew it was a long term shot before sales came through the door. Given that the De Novo process is only due to be completed by April next year.. I would not expect to see real revenue stream until later that year. However I reckon in 18 months we will know the full potential. I have no exit strategy at this stage in terms of how high it goes... But I would potentially exit if it does not get approval from teh FDA (which I think is less than 0.1%). But if it does do well... realistically who knows what it could be worth? But I honestly believe that a $10 share price is not unrealistic in the next 2 or so years.... but would I bet my house on it... NO! This stock represents about 1.5% of my holdings.

    I am not a heavy trader and just invest on the side... and I prefer to hold medium to long term (I am not sure I have ever held a stock for less than 3 to 6 months).

    If you want to see another great prospect long term.. check out MX1.... was sold on that too and I reckon it is at a good price (57.5c now and floated at 50c last week).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.1¢
Change
0.000(0.00%)
Mkt cap ! $6.684M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
8 10088767 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 83302138 41
View Market Depth
Last trade - 16.21pm 30/07/2025 (20 minute delay) ?
AXP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.